200,000+ products from a single source!
sales@angenechem.com
167817-55-2 | L-Phenylalanine, 2-iodo-
CAS No: 167817-55-2 Catalog No: AG001XLY MDL No:MFCD01860665
Product Description
Catalog Number:
AG001XLY
Chemical Name:
L-Phenylalanine, 2-iodo-
CAS Number:
167817-55-2
Molecular Formula:
C9H10INO2
Molecular Weight:
291.0857
MDL Number:
MFCD01860665
IUPAC Name:
(2S)-2-amino-3-(2-iodophenyl)propanoic acid
InChI:
InChI=1S/C9H10INO2/c10-7-4-2-1-3-6(7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1
InChI Key:
BKXVGLPBXYBDDM-QMMMGPOBSA-N
SMILES:
OC(=O)[C@H](Cc1ccccc1I)N
Properties
Complexity:
187
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
290.976g/mol
Formal Charge:
0
Heavy Atom Count:
13
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
291.088g/mol
Monoisotopic Mass:
290.976g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
63.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.9
Literature
| Title | Journal |
|---|---|
| Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma. | European journal of nuclear medicine and molecular imaging 20101201 |
| 99mTc-tetrofosmin SPECT for the evaluation of cerebral lesions. | European journal of nuclear medicine and molecular imaging 20101201 |
| Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging. | Cancer biotherapy & radiopharmaceuticals 20100401 |
| PET imaging with p-[I-124]iodo-l-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma. | Clinical nuclear medicine 20080601 |
| The use of [123I]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: in vitro R1M rabdomyosarcoma cell and in vivo mouse experiments. | Cancer biotherapy & radiopharmaceuticals 20080401 |
| Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine. | Nuclear medicine communications 20071001 |
| Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging. | Cancer biotherapy & radiopharmaceuticals 20060601 |
| Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine. | Nuclear medicine and biology 20060101 |
| Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice. | Nuclear medicine and biology 20060101 |
| In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20051201 |
| In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050301 |
| Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT. | Nuclear medicine and biology 20040801 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.